Header Logo

Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and Multimorbidity.

Tisminetzky M, Gurwitz JH, Tabada G, Reynolds K, Fortmann SP, Garcia E, Pham T, Goldberg R, Go AS. Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and Multimorbidity. Am J Med. 2022 12; 135(12):1468-1477.

View in: PubMed